Navigation Links
Ethigen Launches Next Generation (NGS) BRCA Testing With Expanded Hereditary Cancer Panel
Date:6/19/2013

Salt Lake City, UT (PRWEB) June 19, 2013

Ethigen announced today the US launch of their expanded BRCA1 and BRCA2 testing service, providing next-generation sequencing (NGS) and rearrangement analysis of both genes. Analysis is available individually, or as part of an expanded hereditary cancer panel, including full coverage of up to seventeen additional genes with known links to cancer risk: MLH1, MSH2, MSH6, APC, MUTYH (MYH), PTEN, TP53, CDK4, STK11, SMAD4, BMPR1A, CDH1, MET, FH, FLCN, PDGFRA, and KIT.

The expanded panel represents the most advanced and comprehensive hereditary cancer analysis in the market today. Genetics professionals may select BRCA analysis only, or select from any combination of the other seventeen available genes at no additional cost. This unique structure provides clinicians with the ability to tailor the breadth of analysis to the patient’s specific family history and desire for information.

“We’re entering a new era of testing for hereditary cancer risk, with better and more complete tests available at increasingly affordable price points,” said Eric M. Dyer, President of Ethigen, LLC. "Ethigen is thrilled to be leading the industry with the most comprehensive and rationally-priced BRCA testing solution available, enabling patients and their health care providers make the most informed, personalized decisions possible.”

Ethigen provides CLIA-certified NGS testing services for numerous genetic disorders, with a primary focus on the hereditary cancer syndromes including hereditary breast and ovarian cancer (HBOC), Lynch syndrome, and the varied polyposis syndromes. Founded in 2011, the company works exclusively with licensed genetics professionals.

“With these more inclusive tests, the need for specific training in the interpretation and reporting of potentially complex genetic results has never been more important. Ethigen strongly advocates for the involvement of a Certified Genetic Counselor, and requires their participation with every test we offer,” said Dyer. “We look forward to working in partnership with the genetic counseling community to better serve the multitudes of individuals who remain in need of appropriate counseling and testing for these common and highly manageable disorders.”

About Ethigen™

Ethigen is a privately-held, international provider of laboratory testing services, committed to ensuring a more informed and responsible future for genetic testing. Ethigen is driven by three guiding principles: to provide the most advanced, clinically relevant genetic testing solutions possible; to encourage more fair and rational pricing for genetic testing services; and to aggressively advocate for the critical role served by the Certified Genetic Counselor throughout the testing process.

Ethigen’s services are certified by the College of American Pathologists (CAP), Clinical Laboratories Improvement Act (CLIA), and Clinical Pathology Accreditation (CPA), with a primary emphasis on the hereditary cancer disorders affecting millions worldwide.

Ethigen seeks to always maintain an ethical awareness of the small but important role it plays in ensuring that genetic science is always used to advance the best interests of patients, genetics professionals, and the community at large. For more information, visit http://www.ethigen.net.

Media Contact:
Eric M. Dyer, President
edyer(at)ethigen(dot)net
(888) 578-7872
http://www.ethigen.net

Read the full story at http://www.prweb.com/releases/Ethigen/BRCA/prweb10843704.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. UH Case Medical Center launches novel clinical trial using stem cells to prevent amputation
2. Canabud.ca Launches Website and Provides link to new Canadian Marijuana for Medical Purposes Regulation
3. South Bay Vascular Center and Vein Institute Launches New Campaign to Promote Men’s Health During Men’s Health Month
4. Novant Health Vein Specialists Launches New Campaign to Promote Men’s Health During Men’s Health Month
5. Filtersfast.com Launches Spazazz Aromatherapy Spa & Bath Crystals
6. C8 Lawsuit News: Wright & Schulte LLC Launches C8 Facebook Page to Provide Up-to-Date Information On C8 Exposure and C8 Lawsuits in Ohio and West Virginia
7. GB HealthWatch Launches Gene-Based Weight Control eTool
8. Insect Shield® Launches Repellent Outdoor Blanket
9. Double PhD launches long duration assistance package
10. International Yoga Training School Launches At-Home Version of Hot Yoga
11. Renowned Rim Fitments Expert, SizeItUp Launches The Database Integrations for the 2012 Nissan GT-R
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain ... for a minimum wage raise to $12 an hour by 2020 and then adjusting it ... the lost value of the minimum wage, assure the wage floor does not erode again, ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
(Date:6/24/2016)... , June 24, 2016 According ... by Type (Standard Pen Needles, Safety Pen Needles), Needle ... GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - ... This report studies the market for the forecast period ... reach USD 2.81 Billion by 2021 from USD 1.65 ...
Breaking Medicine Technology: